Safety and Precautions Side Effect Profile Based on available research, 5-Amino-1MQ appears to have a favorable safety profile: Rodent studies have found no significant adverse effects No established human toxicity profile is currently available The most commonly reported effect is potential sleep disturbance An acclimation period may be necessary, with some subjects reporting decreased exercise tolerance with cardiovascular exercise during initial treatment Special Populations and Contraindications Due to limited safety data, the following populations should exercise caution or avoid use until more research is available: Pregnant or breastfeeding individuals Those with chronic health conditions Individuals taking medications that might interact with 5-Amino-1MQ Takeaway 5-Amino-1MQ represents a promising approach for addressing metabolic disorders through NNMT inhibition

**Other Indications:** May be used as part of a treatment regimen for certain metabolic disorders or conditions that require vitamin B12 supplementation
Highly recommend this practice
Parenteral thiamine can in rare instances trigger an acute allergic response characterized by hypotension, breathlessness, itching, and swelling
For severe deficiency, the AAFP recommends loading doses typically daily or every other day for one to two weeks followed by monthly maintenance injections
AHK-Cu, a synthetic copper tripeptide with the INCI name Copper Tripeptide-3, is one of the few topical compounds with published evidence that it directly stimulates dermal papilla cell proliferation